RxDoctor Payments DataLook up a doctor →

Andrea Deleo

Neurology · Munster, INNPI 1265436042

Payments from drug & device makers

$51,335in general payments, 2019–2025

Across 591 payments — averaging $86.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acorda Therapeutics, Inc$27K
  • AbbVie$11K
  • Amgen$2K
  • Acadia Pharmaceuticals Inc$2K
  • Amneal Pharmaceuticals LLC$1K
  • Kyowa Kirin, Inc.$1K
  • plus $8K from 51 others

What the payments were for

  • Consulting fees$8,51317%
  • Speaking & faculty fees$30,19859%
  • Travel & lodging$1,2782%
  • Food & beverage$11,33722%
  • Education$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Acorda Therapeutics, Inc54$26,712
AbbVie(2 entities)126$10,840
Amgen12$2,112
Acadia Pharmaceuticals Inc23$1,739
Amneal Pharmaceuticals LLC25$1,124
Kyowa Kirin, Inc.5$1,120
Abbott14$686
Jazz Pharmaceuticals Inc.26$654
Biogen23$598
Avadel CNS Pharmaceuticals, LLC16$505
Neurocrine Biosciences, Inc.25$480
SK Life Science, Inc.22$390
Teva Pharmaceuticals USA, Inc.18$303
Lundbeck LLC15$290
MDD US Operations, LLC14$255
AstraZeneca(2 entities)12$250
Pfizer13$245
Boston Scientific5$215
Novartis10$213
UCB, Inc.11$202
Neurelis, Inc.7$193
Sunovion Pharmaceuticals Inc.8$157
Argenx US, Inc.7$148
Biohaven Pharmaceutical Holding Company Ltd.11$143
Supernus Pharmaceuticals, Inc.7$139
W. L. Gore & Associates, Inc.1$138
Lilly USA, LLC8$131
Johnson & Johnson6$121
Banner Life Sciences, LLC6$120
Sanofi5$93
Eisai Inc.4$71
Harmony Biosciences LLC4$70
Upsher-smith Laboratories LLC5$70
Corium, LLC3$70
Vertical Pharmaceuticals, LLC1$68
Adamas Pharmaceuticals, Inc.4$58
Saol Therapeutics Inc.2$58
Takeda Pharmaceuticals U.S.A., Inc.2$56
EMD Serono, Inc.4$53
Medtronic(2 entities)3$49
Avanir Pharmaceuticals, Inc.3$42
Mallinckrodt Hospital Products Inc.3$39
TG Therapeutics, Inc.2$36
Azurity Pharmaceuticals, Inc.2$32
Impel Pharmaceuticals Inc.2$27
Genentech USA, Inc.1$25
Octapharma USA, Inc.1$24
Microtransponder, Inc.1$23
Otsuka America Pharmaceutical, Inc.1$21
E.r. Squibb & Sons, L.L.C.1$19
Cycle Pharmaceuticals Inc1$18
Aucta Pharmaceuticals, Inc.1$17
Merz Pharmaceuticals, LLC1$16
Biohaven Pharmaceuticals, Inc.1$16
Avion Pharmaceuticals1$15
Xeris Pharmaceuticals, Inc.1$14
Arbor Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$51,335 in reported general payments places this provider in the 80th percentile of 308 neurology providers in Indiana.

See all neurology providers in Indiana

Medicare billing

Part B allowed, 2024
$575,890
Medicare patients
902
Services billed
46,796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NeuproRotigotine131$159,301
DuopaCarbidopa/Levodopa25$146,771
RytaryCarbidopa/Levodopa83$122,927
NuplazidPimavanserin Tartrate21$112,597
WakixPitolisant Hcl14$107,913
BotoxOnabotulinumtoxina41$58,233
FingolimodFingolimod Hcl16$55,598
Carbidopa-Levodopa ErCarbidopa/Levodopa332$32,520
GocovriAmantadine Hcl14$31,741
Tetrabenazine14$26,491
Teriflunomide17$25,682
Entacapone82$21,348
Nurtec OdtRimegepant Sulfate13$14,076
Rivastigmine35$10,715
Aimovig AutoinjectorErenumab-Aooe12$10,354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieDuopa, Botox$10,840$205,00466 claims
UCB, Inc.Neupro$202$159,301131 claims
Amneal Pharmaceuticals LLCRytary$1,124$122,92783 claims
Acadia Pharmaceuticals IncNuplazid$1,739$112,59721 claims
Harmony Biosciences LLCWakix$70$107,91314 claims
MDD US Operations, LLCGocovri$255$31,74114 claims
PfizerNurtec Odt, Dilantin$245$19,10230 claims
Arbor Pharmaceuticals, Inc.Horizant$14$6,47011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 308 neurology providers in Indiana.

Other neurology in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →